U.S. Physical Therapy, Inc. (NYSE:USPH) COO Glenn Mcdowell sold 1,004 shares of the firm’s stock in a transaction that occurred on Tuesday, August 29th. The stock was sold at an average price of $57.01, for a total transaction of $57,238.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Glenn Mcdowell also recently made the following trade(s):

  • On Wednesday, August 30th, Glenn Mcdowell sold 2,598 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $57.00, for a total transaction of $148,086.00.
  • On Tuesday, August 22nd, Glenn Mcdowell sold 1,664 shares of U.S. Physical Therapy stock. The stock was sold at an average price of $59.91, for a total transaction of $99,690.24.

U.S. Physical Therapy, Inc. (NYSE:USPH) traded down 0.17% during trading on Friday, hitting $59.80. The stock had a trading volume of 51,673 shares. The stock’s 50-day moving average is $61.26 and its 200-day moving average is $64.94. U.S. Physical Therapy, Inc. has a 52-week low of $51.96 and a 52-week high of $78.00. The stock has a market capitalization of $752.34 million, a PE ratio of 37.85 and a beta of 1.06.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Thursday, August 3rd. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.60 by $0.01. The business had revenue of $104.25 million during the quarter, compared to analyst estimates of $102.93 million. U.S. Physical Therapy had a return on equity of 12.91% and a net margin of 5.65%. On average, analysts predict that U.S. Physical Therapy, Inc. will post $2.13 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 8th. Shareholders of record on Monday, August 21st will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.34%. The ex-dividend date is Thursday, August 17th. U.S. Physical Therapy’s dividend payout ratio is presently 46.78%.

ILLEGAL ACTIVITY WARNING: “Insider Selling: U.S. Physical Therapy, Inc. (USPH) COO Sells 1,004 Shares of Stock” was reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.watchlistnews.com/insider-selling-u-s-physical-therapy-inc-usph-coo-sells-1004-shares-of-stock/1536819.html.

A number of brokerages have recently commented on USPH. Zacks Investment Research cut shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Thursday, June 1st. BidaskClub cut shares of U.S. Physical Therapy from a “sell” rating to a “strong sell” rating in a report on Sunday, July 16th. Cantor Fitzgerald began coverage on shares of U.S. Physical Therapy in a report on Monday, July 24th. They set an “overweight” rating and a $72.00 target price on the stock. Finally, Jefferies Group LLC set a $65.00 target price on shares of U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, August 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $67.25.

A number of large investors have recently modified their holdings of the company. BlackRock Inc. increased its stake in shares of U.S. Physical Therapy by 166,319.0% in the first quarter. BlackRock Inc. now owns 1,554,353 shares of the company’s stock valued at $101,501,000 after buying an additional 1,553,419 shares in the last quarter. Aberdeen Asset Management PLC UK increased its stake in shares of U.S. Physical Therapy by 13.4% in the second quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock valued at $42,582,000 after buying an additional 83,253 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of U.S. Physical Therapy by 10.4% in the second quarter. Renaissance Technologies LLC now owns 668,074 shares of the company’s stock valued at $40,352,000 after buying an additional 63,074 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of U.S. Physical Therapy by 2.2% in the second quarter. Vanguard Group Inc. now owns 655,524 shares of the company’s stock valued at $39,594,000 after buying an additional 13,991 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of U.S. Physical Therapy by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 486,775 shares of the company’s stock valued at $29,401,000 after buying an additional 3,853 shares in the last quarter. 95.50% of the stock is owned by institutional investors and hedge funds.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.